Samir R. Patel

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Vancouver, WA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Abizer Gaslightwala, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Samir R. Patel

Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
American Depositary Shares representing Ordinary Shares
Shares / value
98,241
Estimated value
$3,394,726
Report date
07 Jul 2026
Price
$1.12
Ownership
PranaBio Investments LLC
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
Ordinary Shares, par value $0.0001 per share
Shares / value
5,249,511,500
Estimated value
$3,149,707
Report date
03 Jan 2025
Price
$0.000600
Ownership
PranaBio Investments LLC
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
Series A Warrants (Right to Buy)
Shares / value
406,250
Estimated value
$455,000
Report date
06 Mar 2025
Price
$1.12
Ownership
PranaBio Investments LLC
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
Series B Warrants (Right to Buy)
Shares / value
406,250
Estimated value
$455,000
Report date
06 Mar 2025
Price
$1.12
Ownership
PranaBio Investments LLC
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
Pre-Funded Warrants to purchase ADRs
Shares / value
618,658
Estimated value
$249,999
Report date
16 Dec 2025
Price
$0.4041
Ownership
Direct
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
Pre-Funded Warrants to purchase ADRs
Shares / value
231,997
Estimated value
$93,749
Report date
16 Dec 2025
Price
$0.4041
Ownership
PranaBio Investments LLC
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
Ordinary Shares, par value $0.0001 per share
Shares / value
91,396,000
Estimated value
$54,838
Report date
03 Jan 2025
Price
$0.000600
Ownership
Direct
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
American Depositary Shares representing Ordinary Shares
Shares / value
3,566
Estimated value
$51,182
Report date
07 Jul 2026
Price
$1.12
Ownership
Direct
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
Warrants to purchase American Depositary Shares ("ADRs")
Shares / value
618,658
Estimated value
Report date
16 Dec 2025
Price
Ownership
Direct
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
Warrants to purchase ADRs
Shares / value
231,997
Estimated value
Report date
16 Dec 2025
Price
Ownership
PranaBio Investments LLC
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
Stock Option (Right to Buy)
Shares / value
225,000
Estimated value
Report date
20 Mar 2025
Price
Ownership
Direct
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director

CytoDyn Inc.

Security class
Non-qualified Stock Option
Shares / value
12,329
Estimated value
Report date
24 Nov 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
Pre-Funded Warrant to purchase ADSs
Shares / value
0
Estimated value
Report date
07 Jul 2026
Price
Ownership
PranaBio Investments LLC
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount
Form 4 holding Director, 10%+ Owner

Akari Therapeutics Plc

Security class
Pre-Funded Warrant to purchase American Depositary Shares
Shares / value
0
Estimated value
Report date
07 Jul 2026
Price
Ownership
PranaBio Investments LLC
Underlying class
American Depositary Shares representing Ordinary Shares
Underlying amount

Insider Reports Filed by Samir R. Patel

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .